Ferdinand Hui, MD, discusses the endovascular treatment of cerebral venous disorders, a potentially vast...
SmartTRAK highlights three neurointerventional trends to watch in 2026. SmartTRAK highlights recent news...
Abbott‘s VP of Neuromodulation Ryan Lakin discusses his vision for neuromodulation and trends in the mar...
Raul Nogueira, MD, discusses the latest research and innovation in super-bore catheters for the treatmen...
Stewart Strong, Q’Apel Medical’s recently appointed CEO, discusses the company, his priorities and plans...
SmartTRAK is excited to attend the Society of Neurointerventional Surgery’s (SNIS) 22nd Annual Meeting &...
Scientia Vascular CEO Rick Randall discusses the company, its novel technology and plans for growth in a...
Perfuze CEO Wayne Allen discusses the company, its novel technology and how the company plans to capture...
Dr. Marc Russo discusses his research on ultra-low frequency SCS and its potential to treat nociceptive ...
Carsten Schroeder, president and CEO of Terumo Neuro, discusses the company’s plans to capture share and...